Search

Search Constraints

You searched for: Author/Creator Peggs, Karl S.

Search Results

1. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. (17th December 2018)

4. Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure. (18th January 2014)

5. Autologous stem cell transplantation outcomes in elderly patients with B cell Non‐Hodgkin Lymphoma. (26th June 2015)

6. Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party1. Issue 1 (23rd October 2018)

7. Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. (22nd February 2018)

8. Comparative analysis of melphalan versus busulphan T‐cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia. (8th August 2019)

10. Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Issue 30 (20th October 2021)